CorMedix Inc. — Director's Dealing 2011

Dec 20, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2011-12-16

Reporting Person: Gelbfish Gary A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-16	Common Stock, $0.001 par value per share	P	23300	$0.3313	Acquired	259540	Direct

Footnotes

F1: Includes (i) 94,496 shares of our common stock held jointly by Dr. Gelbfish and his wife, (ii) 70,872 shares of our common stock held by Dr. Gelbfish as custodian for certain of his children, and (iii) 70,872 shares of our common stock held by Landmark Foundation, of which Dr. Gelbfish and his wife are trustees.